[LGND] QoQ Quarter Result on 30-Jun-2015 [#Q2]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
04-Aug-2015
Financial Year
2015
Quarter
30-Jun-2015 [#Q2]
Profit Trend
QoQ- 3,025.20%
YoY- 1,380.15%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Revenue 29,648 21,192 17,701 18,418 14,602 22,998 14,973 57.61%
PBT 9,571 5,826 7,284 22,292 -74 7,012 901 382.53%
Tax 3,694 -515 -217,255 265 15 279 124 859.00%
NP 6,608 6,341 199,165 23,564 754 7,055 1,280 198.40%
Tax Rate -38.60% 8.84% 2,982.63% -1.19% - -3.98% -13.76% -
Total Cost 23,040 14,851 -181,464 -5,146 13,848 15,943 13,693 41.42%
Ratio Analysis
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
NP Margin 22.29 29.92 1,125.16 127.94 5.16 30.68 8.55 89.31%
Per Share
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
EPS 0.32 0.32 10.01 1.19 0.04 0.35 0.06 204.94%
EPS Diluted 0.30 0.29 9.28 1.11 0.04 0.34 0.06 192.11%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.